Next 10 |
home / stock / cde / cde articles
Shares of Ovid Therapeutics Inc (NASDAQ:OVID) dipped 65.7% to $1.1285 after Takeda’s Skyline study in Dravet syndrome missed its primary endp...
Source: Clive Maund 05/22/2024 Technical Analyst Clive Maund shares six silver stocks he thinks are ready to advance. It was looking increasingly l...
U.S. stocks were mixed, with the Dow Jones gaining around 0.1% on Friday. Shares of Despegar.com, Corp. (NYSE:DESP) rose sharply during Friday'...
U.S. stock futures were slightly lower this morning, with the Nasdaq futures falling around 0.1% on Tuesday. Shares of Medifast, Inc. (NYSE:MED) fe...
U.S. stock futures were higher this morning, with the Dow futures gaining over 150 points on Monday. Shares of Tesla, Inc. (NASDAQ:TSLA) fell sharp...
U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE: AGX) rose sharply during Friday&r...
Top Stories for April 10, 2024: 1. Gatos Silver Inc (NYSE:GATO) announced its first quarter 2024 production results for the Cerro Los Gatos mine in...
Coeur Mining, Inc. (NYSE: CDE) announced that its newly expanded Rochester silver and gold mine in Nevada achieved commercial production. On Mar 7,...
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during T...
News, Short Squeeze, Breakout and More Instantly...
Recent assays highlight the potential to extend its reserve based mine life to over five years by year-end Coeur Mining, Inc. (“Coeur” or the “Company”) (NYSE: CDE) today reported positive results from its multi-year exploration drilling and development progr...
Coeur Mining, Inc.’s (“Coeur” or the “Company”) (NYSE: CDE) Senior Vice President and Chief Financial Officer, Thomas S. Whelan, and Senior Vice President and Chief Operating Officer, Michael “Mick” Routledge, will participate in the Canaccord Glob...
2024-05-03 09:30:10 ET BMO Capital analyst issues POSITIVE recommendation for CDE on May 3, 2024 07:11AM ET. The previous analyst recommendation was Outperform. CDE was trading at $4.79 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curr...